| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06352281 | Efficacy and Safety of CAR-T Cells Therapy for Chronic or Refractory Primary Immune… | ITP - Immune Thrombocytopenia | Recruiting |
| NCT06675422 | JY231 Injection for the Treatment of Active Systemic Lupus Erythematosus (SLE) | Systemic Lupus Erythematosus (SLE) | Recruiting |
| Early Phase 1 | |||
| NCT06820424 | Safety and Preliminary Efficacy of Anti-CDH17 CAR-T Cell Therapy in Patients with… | CDH17-positive Advanced Solid Tumors | Recruiting |
| NCT06514768 | JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL) | B-cell Acute Lymphoblastic Leukemia (B-ALL) | Recruiting |
| Not specified | |||
| NCT06515262 | Safety and Efficacy of Anti-BCMA-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM | Relapsed/Refractory Multiple Myeloma | Recruiting |
| NCT07065279 | JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies | B-cell Malignancies | Recruiting |